XML 66 R48.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Summary of significant accounting policies (Details Narrative)
12 Months Ended
Feb. 16, 2024
shares
Oct. 06, 2023
shares
Mar. 23, 2023
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Dec. 31, 2023
SGD ($)
$ / shares
shares
Dec. 31, 2022
SGD ($)
shares
Dec. 31, 2021
SGD ($)
shares
Dec. 31, 2023
SGD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2022
SGD ($)
Product Information [Line Items]                    
Convenience translation rate | (per share)       $ 0.7580 $ 1.00          
Allowance for doubtful accounts for accounts receivable       $ 7,430     $ 23,210 $ 9,802   $ 9,102
Legal fees                 $ 504,567 676,321
Balance, shares   171,384 2,800,000              
Public offering deferred costs       87,012     114,794   676,321
Capitalized computer software cost       700,000       900,000    
Contract liabilities       78,568     78,340 103,655   194,300
Advertising expense       690,559 $ 911,055 $ 1,037,772 845,793      
Research and development, net       853,101 1,125,496          
Selling and marketing expenses       1,362,111 $ 1,797,033 $ 1,926,003 1,717,470      
Government grant       $ 19,532     $ 492,404 $ 25,769   $ 248,067
Diluted       18,461,340 18,461,340 16,250,000 16,250,000      
Basic       17,860,622 17,860,622 16,250,000 16,250,000      
Customer Concentration Risk [Member] | Accounts Receivable [Member] | One Customer [Member]                    
Product Information [Line Items]                    
Concentration risk percentage       10.00% 10.00%          
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Two Customer [Member]                    
Product Information [Line Items]                    
Concentration risk percentage       25.85% 25.85%          
Customer Concentration Risk [Member] | Accounts Receivable [Member] | No Customers [Member]                    
Product Information [Line Items]                    
Concentration risk percentage           10.00% 10.00%      
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | One Customer [Member]                    
Product Information [Line Items]                    
Concentration risk percentage           42.40%        
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | No Customers [Member]                    
Product Information [Line Items]                    
Concentration risk percentage       10.00% 10.00% 10.00% 10.00%      
Supplier Concentration Risk [Member] | Revenue Benchmark [Member] | Two Vendor [Member]                    
Product Information [Line Items]                    
Concentration risk percentage           15.40%        
Supplier Concentration Risk [Member] | Purchases [Member] | One Vendor [Member]                    
Product Information [Line Items]                    
Concentration risk percentage           17.00% 31.20%      
Supplier Concentration Risk [Member] | Purchases [Member] | Three Vendor [Member]                    
Product Information [Line Items]                    
Concentration risk percentage           12.80%        
Supplier Concentration Risk [Member] | Purchases [Member] | No Vendor [Member]                    
Product Information [Line Items]                    
Concentration risk percentage       10.00% 10.00%          
Supplier Concentration Risk [Member] | Accounts Payable [Member] | Vendors One [Member]                    
Product Information [Line Items]                    
Concentration risk percentage       29.00% 29.00%          
Supplier Concentration Risk [Member] | Accounts Payable [Member] | One Vendors [Member]                    
Product Information [Line Items]                    
Concentration risk percentage       22.10% 22.10%   15.40%      
Supplier Concentration Risk [Member] | Accounts Payable [Member] | Two Vendors [Member]                    
Product Information [Line Items]                    
Concentration risk percentage       10.40% 10.40%          
Software and Software Development Costs [Member]                    
Product Information [Line Items]                    
Estimated useful life       5 years       5 years    
IPO [Member]                    
Product Information [Line Items]                    
Balance, shares     2,800,000              
Public offering deferred costs       $ 87,012       $ 114,794    
IPO [Member] | Subsequent Event [Member]                    
Product Information [Line Items]                    
Balance, shares 3,555,555